Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/ARCH stock hub

TSXV/ARCH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/ARCHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

29.8M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/ARCH

In the news

Latest news · TSXV/ARCH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/ARCH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

CAD

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 32.4M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA03938C1041
Last refreshed	2026-05-10
Market cap	CAD 29.8M
Price	CAD 0.44
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsxv/ARCH
Website	https://www.archbiopartners.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.04%
EV Earnings	-12.03x
EV/Sales	205.54x
P/B ratio	-8.28x
P/S ratio	188.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-284.9%
Gross Profit	CAD -450,368
Net Income	CAD -2.7M
Net Income Growth Years	1%
Pretax Margin	-1,705.36%
ROA	-524
Roa5y	-122.2
ROCE	65.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.18%
Cagr1y	-74.28%
Cagr3y	-40.92%
Cagr5y	-18.64%
EPS Growth Years	1
Revenue Growth	-91.86x
Revenue Growth Years	0x
Revenue Growth3 Y	-45.27x
Revenue Growth5 Y	30.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.57
Assets	CAD 25,032
Cash	CAD 4,163
Current Assets	CAD 25,032
Current Liabilities	CAD 3.6M
Debt	CAD 2.6M
Equity	CAD -3.6M
Interest Coverage	-8.57
Liabilities	CAD 3.6M
Long Term Assets	CAD 0
Long Term Liabilities	CAD 0
Net Cash	CAD -2.6M
Net Cash By Market Cap	CAD -8.82
Tangible Book Value	CAD -3.6M
Tangible Book Value Per Share	CAD -0.05
WACC	14.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.01
Net Working Capital	CAD -969,883
Quick ratio	0
Working Capital	CAD -3.6M
Working Capital Turnover	CAD -0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-11.22%
1Y total return	-74.26%
200-day SMA	1.1
3Y total return	-79.38%
50-day SMA	0.58
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.34%
All Time High	5.3
All Time High Change	-91.79%
All Time High Date	2021-12-01
All Time Low	0.2
All Time Low Change	117.5%
All Time Low Date	2015-07-15
ATR	0.04
Beta	2.05
Ch YTD	-64.34
High	0.44
High52	1.95
High52 Date	2025-06-09
High52ch	-77.69%
Low	0.41
Low52	0.39
Low52 Date	2026-05-07
Low52ch	11.54%
Ma50ch	-24.69%
Price vs 200-day SMA	-60.56%
RSI	38.47
RSI Monthly	28.51
RSI Weekly	25.03
Sharpe ratio	-1.69x
Sortino ratio	-2.18
Total Return	-2.96%
Tr YTD	-64.34
Tr1m	-26.27%
Tr3m	-44.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.3M
Operating margin	-1,481.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,929,040%
Net Borrowing	-380,610
Shares Insiders	22.09%
Shares Qo Q	0.91%
Shares Yo Y	2.96%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	66,734.5x
Bv Per Share	-0.05
Ch10y	-11.22
Ch1m	-26.27
Ch1y	-74.26
Ch3m	-44.23
Ch3y	-79.38
Ch5y	-64.34
Ch6m	-58.96
Change	6.1%
Change From Open	4.82
Close	0.41
Days Gap	1.22
Dollar Volume	11,362.6
Earnings Date	2026-05-29
EBIT	CAD -2.3M
EPS	CAD -0.04
F Score	1
Financing CF	1,480,280
Fiscal Year End	September
Is Primary Listing	0
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Ma150	0.93
Ma150ch	-53.15%
Ma20	0.46
Ma20ch	-4.71%
Net CF	-50,686
Next Earnings Date	2026-05-29
Open	0.42
Position In Range	100
Price Date	2026-05-08
Relative Volume	0.39x
Revenue	158,079x
Tr6m	-58.96%
Volume	26,121

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/ARCH pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/ARCH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/ARCH?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+22.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.0%

Negative means the company is buying back shares.

Technical

TSXV/ARCH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.5

Neutral momentum band

Price vs 200-day MA

-60.6%

50/200-day relationship not available

Beta (5Y)

2.05

More volatile than the market

Sharpe ratio

-1.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/ARCH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/ARCH stock rating?

tsxv/ARCH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/ARCH analysis?

The full report lives at /stocks/tsxv/ARCH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/ARCH?

The latest report frames tsxv/ARCH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/ARCH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.